# FDA recall D-0766-2022

> **Aurobindo Pharma USA Inc.** · Class III · drug recall initiated 2022-04-05.

## Product

Cyanocobalamin Injection, USP, 1,000 mcg per mL, For IM or SC Use Only, 1 mL Vial, Rx Only, Manufactured in India, for Auromedics Pharma LLC, NDC 55150-364-01.

## Reason for recall

Subpotent Drug: Out of Specification results for Assay

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-0766-2022
- **Recalling firm:** Aurobindo Pharma USA Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-04-05
- **Report date:** 2022-04-20
- **Termination date:** 2024-06-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** East Windsor, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0766-2022

## Citation

> AI Analytics. FDA recall D-0766-2022. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0766-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*